HMI-LUSC: A Histological Hyperspectral Imaging Dataset for Lung Squamous Cell Carcinoma.
Hyperspectral imaging (HSI) is a three-dimensional imaging technique that integrates spectroscopy and imaging.
APA
Yan Z, Huang H, et al. (2026). HMI-LUSC: A Histological Hyperspectral Imaging Dataset for Lung Squamous Cell Carcinoma.. Scientific data, 13(1). https://doi.org/10.1038/s41597-026-06766-7
MLA
Yan Z, et al.. "HMI-LUSC: A Histological Hyperspectral Imaging Dataset for Lung Squamous Cell Carcinoma.." Scientific data, vol. 13, no. 1, 2026.
PMID
41673396
Abstract
Hyperspectral imaging (HSI) is a three-dimensional imaging technique that integrates spectroscopy and imaging. When combined with microscopy, hyperspectral microscopic imaging (HMI) captures rich spatial-spectral information at the cellular scale, offering new avenues for histopathological analysis. Conventional pathological diagnosis relies on manual inspection of stained slides, which is time-consuming, subjective, and limited in capturing biochemical variations. While machine learning combined with HMI has shown promise in improving diagnostic accuracy and automation, progress remains constrained by the lack of publicly available datasets, especially for lung cancer, one of the most common malignant tumors worldwide. To address this gap, we present HMI-LUSC, the first open HMI dataset for lung squamous cell carcinoma (LUSC). The dataset was acquired using a custom HMI system and includes 62 hyperspectral images from 10 patients, spanning 450-750 nm across 61 spectral bands, with pathologist-provided tumor annotations and refined cell-level labels generated via a semi-automated workflow. HMI-LUSC provides a robust benchmark for spectral analysis and tumor detection, fostering future advances in computational pathology and spectral diagnostic research.
MeSH Terms
Humans; Lung Neoplasms; Carcinoma, Squamous Cell; Hyperspectral Imaging; Microscopy
같은 제1저자의 인용 많은 논문 (5)
- Impact of Genetic Variants on Colorectal Cancer Risk: A Case-Control Study.
- USP9X promotes acute myeloid leukemia progression and adriamycin resistance by regulating METTL7A deubiquitination.
- Interpretable Deep Learning with Multi-Scale CT for Predicting Occult Lymph Node Metastasis in Early-Stage NSCLC: A Multicenter Study.
- Risk of adverse events in elotuzumab-treated patients with multiple myeloma: a systematic review and meta-analysis.
- Lymphedema Care after Breast Cancer Surgery: Insights from a New Meta-Analysis.